Encompass Health Corp (AMEX:EHC) has been given an average recommendation of “Hold” by the fourteen research firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $57.78.

Several equities research analysts recently commented on the company. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a report on Tuesday, January 30th. Credit Suisse Group assumed coverage on Encompass Health in a report on Wednesday, January 17th. They set an “outperform” rating and a $58.00 target price on the stock. Stephens reiterated a “buy” rating and set a $55.00 target price on shares of Encompass Health in a report on Friday, January 12th. Wells Fargo & Co assumed coverage on Encompass Health in a report on Tuesday, January 30th. They set a “market perform” rating and a $56.00 target price on the stock. Finally, Royal Bank of Canada raised their target price on Encompass Health to $64.00 and gave the company an “outperform” rating in a report on Thursday, March 1st.

How to Become a New Pot Stock Millionaire

Shares of Encompass Health (AMEX EHC) traded up $0.06 during trading hours on Friday, hitting $58.19. The company had a trading volume of 134,745 shares, compared to its average volume of 615,248. The stock has a market cap of $5,720.00, a P/E ratio of 21.47, a P/E/G ratio of 1.70 and a beta of 0.48. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a 1-year low of $40.86 and a 1-year high of $59.29.

Encompass Health (AMEX:EHC) last announced its earnings results on Monday, February 26th. The company reported $0.70 EPS for the quarter, beating the consensus estimate of $0.64 by $0.06. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The company’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the business posted $0.72 EPS. equities research analysts expect that Encompass Health will post 2.72 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Monday, April 2nd will be paid a dividend of $0.25 per share. The ex-dividend date is Thursday, March 29th. This represents a $1.00 dividend on an annualized basis and a yield of 1.72%. Encompass Health’s dividend payout ratio (DPR) is presently 36.90%.

Hedge funds and other institutional investors have recently modified their holdings of the business. FNY Managed Accounts LLC acquired a new stake in Encompass Health during the 4th quarter valued at approximately $125,000. Cerebellum GP LLC acquired a new stake in Encompass Health during the 4th quarter valued at approximately $129,000. Heartland Advisors Inc. acquired a new stake in Encompass Health during the 4th quarter valued at approximately $237,000. Zeke Capital Advisors LLC acquired a new stake in Encompass Health during the 4th quarter valued at approximately $238,000. Finally, S. R. Schill & Associates acquired a new stake in Encompass Health during the 4th quarter valued at approximately $401,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Encompass Health Corp (EHC) Receives $58.00 Average Target Price from Brokerages” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/03/14/encompass-health-corp-ehc-receives-58-00-average-target-price-from-brokerages.html.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.